Status:
RECRUITING
EUS-guided FNB-induced PANCREatitis Assessment
Lead Sponsor:
University of Tehran
Conditions:
Pancreatitis, Acute
EUS Guided Biopsy
Eligibility:
All Genders
18+ years
Brief Summary
This is a descriptive analytical study to investigate the prevalence and risk factors for pancreatitis after Endoscopic Ultrasonography-guided Fine Needle Biopsy (EUS-FNB) in patients at Shariati Hosp...
Detailed Description
EUS-guided tissue acquisition is an advanced diagnostic procedure for evaluating and diagnosing pancreatic, ampullary, and biliary tract tumors due to its high accuracy and minimally invasive nature. ...
Eligibility Criteria
Inclusion
- Inpatients and outpatients aged 18 years or older undergoing EUS-guided FNB from a solid or cystic lesion in one of the following locations:
- Pancreas
- Ampulla of Vater
- Distal CBD, defined as the intrapancreatic portion of the CBD where the FNB needle passes through the pancreas during biopsy
Exclusion
- Patients who undergo concurrent ERCP in the same day
- Patients experiencing an ongoing episode of acute pancreatitis during EUS-FNB
- Patients undergoing EUS-guided FNA
- Uncorrectable coagulopathy (INR \> 1.5)
- Uncorrectable thrombocytopenia (platelet \< 50,000)
- Decline to participate in the study and sign the informed consent form
- Patients undergoing EUS-guided FNB from the proximal CBD where the FNB needle does not traverse the pancreas
Key Trial Info
Start Date :
September 11 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 12 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07168863
Start Date
September 11 2025
End Date
March 12 2027
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shariati Hospital, Digestive Diseases Research Institute
Tehran, Tehran Province, Iran, 1411713135